EMJ Hematology

@EMJHematology

EMJ Hematology is an open-access medical journal for doctors & healthcare professionals. Subscribe at:

United Kingdom
Vrijeme pridruživanja: prosinac 2013.

Tweetovi

Blokirali ste korisnika/cu @EMJHematology

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @EMJHematology

  1. 5. velj

    This article introduces a rare case of a sickle cell disease patient who as a result of acute intrahepatic cholestasis experienced severe complications. To learn more, visit:

    Poništi
  2. 3. velj

    Therapeutic Options in Myelodysplastic Syndromes Following Hypomethylating Agent Failure. The table shows an International Prognostic Scoring System (IPSS). To learn more, visit:

    Poništi
  3. 1. velj

    EMJ Hematology US Edition is the newest addition to our collection, and contains a review of the 61st American Society of (ASH) Annual Meeting and Exposition. Be sure to read it today:

    Poništi
  4. 31. sij

    Have a read of EMJ and find our abstracts just here!

    Poništi
  5. 30. sij

    Tagraxofusp is a Novel Targeted Therapy Directed to CD123

    Poništi
  6. 29. sij

    Explore all EMJ content of articles, abstract and interviews here!

    Poništi
  7. 28. sij

    Autologous Dendritic Cell Vaccination to Prevent Progression and Relapse in Multiple Myeloma

    Poništi
  8. 28. sij

    With over 30,000 delegates in attendance, this bustling congress was packed full of ground-breaking research and discussion of the most pressing topics in . Be sure to check out the full congress review here:

    Poništi
  9. 27. sij

    This case report by Ammouri et al. presents an astute view of the complexity and various presentations of pernicious and novel approaches regarding its diagnosis, pathogenesis, and clinical presentation.

    Poništi
  10. 26. sij

    Brand new articles, abstract summaries and captivating interviews from the field of . Explore our hematology collection today:

    Poništi
  11. 24. sij

    EMJ Hematology US Edition 1.1 presents the latest coverage from the 2019 American Society of (ASH) meeting in . Our first US-affiliated journal includes committee member interviews, abstract reviews and much more. Read it here:

    Poništi
  12. 23. sij

    will soon be publishing its first US Edition Journal providing a wide-ranging review of the 61st American Society of (ASH). Subscribe here to be notified on publication day:

    Poništi
  13. 23. sij

    Throw it all the way back to EMJ 7.1.

    Poništi
  14. 22. sij

    Gilteritinib Plus Azacitidine in Newly Diagnosed FLT3 Mutated (FLT3mut+) Acute Myeloid Patients Ineligible for Intensive Induction : Preliminary Findings from the Safety Cohort:

    Poništi
  15. 21. sij

    For the latest developments in , subscribe to EMJ

    Poništi
  16. 20. sij

    xamples of Epstein–Barr virus-positive diffuse large B cell (A, B, C) and Epstein–Barr virus mucocutaneous (D, E, F).

    Poništi
  17. 19. sij

    Therapeutic Options in Myelodysplastic Syndromes: Established and Emerging Therapies. The table shows an international prognostic scoring system for the stratification of myelodysplastic syndromes.

    Poništi
  18. 18. sij

    Take a moment to enjoy some EMJ video content, just follow this link:

    Poništi
  19. 17. sij

    Blood transfusions: What to know

    Poništi
  20. 17. sij

    Best supplements for lowering blood pressure

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·